Cannvas Adds BNN Bloomberg and BTV to Brand Awareness Campaign

“Working with BNN Bloomberg and BTV allows us to tell our story to a broader investor audience and introduce our global cannabis education platform on a national level,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “The legalization of recreational use of Cannabis in Canada begins October 17th. Consumers, investors, producers, and other participants in the sector recognize the value of what we provide in the marketplace. It’s time we expand market awareness of what we are accomplishing and bringing to the Cannabis space”

About BNN and BTV
BNN Bloomberg – Business News Network is Canada’s only television service devoted exclusively to business and finance news with wall-to-wall coverage of the markets providing Canadian investors with the latest business news, newsmaker interviews and stock market analyses.

BTV-Business Television and CEO Clips produce and house the largest library of company video features and campaigns for publicly traded companies for broadcast on TV and financial sites. Contact info@b-tv.com for more information.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: Media Inquiries: media@cannvasmedtech.com; Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116